Margrete Larsen Burns
Margrete Larsen Burns
MD, PhD, consultant, section manager, Section clinical pharmacology SSE, Oslo university hospital
Verifisert e-postadresse på ous-hf.no
Tittel
Sitert av
Sitert av
År
Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department
ST Bogstrand, PT Normann, I Rossow, M Larsen, J Mørland, Ø Ekeberg
Drug and alcohol dependence 117 (2-3), 132-138, 2011
922011
Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines
A Reimers, JA Berg, ML Burns, E Brodtkorb, SI Johannessen, ...
Drug design, development and therapy 12, 271, 2018
452018
Therapeutic drug monitoring of lacosamide in Norway: focus on pharmacokinetic variability, efficacy and tolerability
T Svendsen, E Brodtkorb, A Baftiu, ML Burns, SI Johannessen, ...
Neurochemical research 42 (7), 2077-2083, 2017
302017
Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice
CJ Landmark, G Beiske, A Baftiu, ML Burns, SI Johannessen
Seizure 28, 88-91, 2015
302015
Therapeutic drug monitoring of clobazam and its metabolite—impact of age and comedication on pharmacokinetic variability
ML Burns, A Baftiu, MS Opdal, SI Johannessen, CJ Landmark
Therapeutic drug monitoring 38 (3), 350-357, 2016
272016
Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway …
A Baftiu, SA Feet, PG Larsson, ML Burns, O Henning, E Sætre, E Molden, ...
Epilepsy research 139, 35-42, 2018
202018
The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice
C Johannessen Landmark, T Svendsen, J Dinarevic, RF Kufaas, ...
Therapeutic drug monitoring 38 (4), 499-505, 2016
202016
The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice
C Johannessen Landmark, T Svendsen, J Dinarevic, RF Kufaas, ...
Therapeutic drug monitoring 38 (4), 499-505, 2016
202016
Long-term stability of GHB in post-mortem samples and samples from living persons, stored at− 20° C, using fluoride preservatives
B Fjeld, ML Burns, R Karinen, B Larssen, A Smith-Kielland, V Vindenes
Forensic science international 222 (1-3), 47-51, 2012
202012
Pharmacokinetic variability of valproate in women of childbearing age
C Johannessen Landmark, ML Burns, A Baftiu, AH Farmen, MI Lossius, ...
Epilepsia 58 (10), e142-e146, 2017
192017
Inotropic therapy in newborns, a population-based national registry study
ML Burns, HJ Stensvold, K Risnes, HJ Guthe, H Astrup, SM Nordhov, ...
Pediatric Critical Care Medicine 17 (10), 948-956, 2016
182016
Pharmacokinetic variability of valproate during pregnancy–implications for the use of therapeutic drug monitoring
CJ Landmark, AH Farmen, ML Burns, A Baftiu, MI Lossius, ...
Epilepsy research 141, 31-37, 2018
132018
Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at-20^ oC
G Hoiseth, B Fjeld, ML Burns, DH Strand, V Vindenes
Forensic Science International 239 (1), 6-10, 2014
112014
Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at− 20° C
G Høiseth, B Fjeld, ML Burns, DH Strand, V Vindenes
Forensic science international 239, 6-10, 2014
82014
Therapeutic drug monitoring of gabapentin in various indications
M Larsen Burns, E Kinge, M Stokke Opdal, SI Johannessen, ...
Acta Neurologica Scandinavica 139 (5), 446-454, 2019
72019
Pharmacology portal: an open database for clinical pharmacologic laboratory services
TK Bjånes, EM Hjertø, L Lønne, L Aronsen, JA Berg, S Bergan, ...
Clinical therapeutics 38 (1), 222-226, 2016
72016
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
K Heger, C Lund, M Larsen Burns, M Bjørnvold, E Sætre, SI Johannessen, ...
Epilepsia Open 5 (3), 432-441, 2020
62020
Pharmacokinetic variability and clinical use of lacosamide in children and adolescents in Denmark and Norway
ML Burns, M Nikanorova, A Baftiu, JB Rasmussen, SI Johannessen, ...
Therapeutic drug monitoring 41 (3), 340-347, 2019
52019
Felles referanseområder for antiepileptika
A Reimers, JA Berg, ML Burns, CJ Landmark
Tidsskrift for Den norske legeforening, 2017
22017
Harmonised reference ranges for antiepileptic drugs
A Reimers, JA Berg, ML Burns, CJ Landmark
Tidsskrift for Den norske legeforening, 2017
22017
Systemet kan ikke utføre handlingen. Prøv igjen senere.
Artikler 1–20